Universal Psychosocial Screening in Childhood Cancer: Comparing Two Implementation Approaches Across 18 U.S. Children’s Cancer Programs

Table of Contents

• Key Points
• Why This Research Matters
• What the Researchers Set Out to Learn
• How the Study Was Designed
• The Two Implementation Strategies
• Getting 18 Cancer Programs Ready to Screen
• What the Researchers Measured
• Key Findings: Strategy I vs. Strategy II
• Four Key Contributions to the Field
• What This Means for Patients and Families
• Study Limitations
• Recommendations for Cancer Programs
• Frequently Asked Questions
• Source Information

Key Points

• A national trial of 18 U.S. children's cancer programs found web-based training plus a written implementation plan supported psychosocial screening.
• Adding consultation calls and a champion did not increase screening rates compared to the simpler training and plan approach.
• Even committed programs screened only a subgroup of families, so true universal screening of all eligible families was not achieved.
• The PAT is a validated English and Spanish caregiver questionnaire that sorts families into universal, targeted, or clinical risk levels.

Why This Research Matters

Psychosocial care (support for the emotional, social, and practical challenges of illness) is a proven part of quality cancer treatment, yet it is delivered unevenly across children’s cancer programs. Research shows that pediatric cancer outcomes differ by race, ethnicity, and socioeconomic status (a family’s income, education, and resources). These gaps appear across many childhood cancer diagnoses and are especially visible in children treated with hematopoietic transplantation (bone marrow or stem cell transplant) for malignancies.

Why do disparities happen? The causes are layered. They include interruptions in care caused by household material hardship (struggling to pay for food, housing, transportation, or medicine) and limited communication when families and providers speak different languages. Children with cancer who carry more psychosocial risk factors also tend to experience a greater symptom burden — more pain, fatigue, and other treatment-related symptoms.

The Institute of Medicine and the Standards of Psychosocial Care in Pediatric Cancer both call for better delivery of these services. The first standard is direct: “Youth with cancer and their family members should routinely receive systematic assessment of their psychosocial healthcare needs.” In other words, every family should be asked, in a consistent way, about how they are coping.

One widely used framework, the Pediatric Psychosocial Preventative Health Model (PPPHM), groups families into three risk levels:

• Universal — most families, who need general support and information
• Targeted — families with moderate, specific concerns
• Clinical — families with high distress or complex needs, who need intensive services

Screening every family reduces bias. When all families answer the same questions, care is not based on a clinician’s personal judgment or assumptions. This helps match resources to what families actually need. Unfortunately, few programs offer this kind of care consistently, despite the availability of valid screening tools that are practical to use in daily clinical care.

What the Researchers Set Out to Learn

This was a comparative effectiveness trial — a study that compares two real-world approaches to see which works better in practice. The researchers wanted to identify implementation strategies that produce higher levels of screening in English and Spanish (called penetration, meaning the percentage of eligible families actually screened) and that promote health equity (fair screening rates across racial, ethnic, and socioeconomic groups).

They also tracked adoption — how many sites enrolled and completed the study, and how many initiated screening. Their main hypothesis was that Strategy II, with expanded implementation resources, would produce higher screening rates overall and greater health equity than Strategy I.

The screening tool used was the Psychosocial Assessment Tool (PAT), a web-based questionnaire completed by a child’s caregiver, validated in both English and Spanish. The PAT is the most widely used psychosocial screening measure in pediatric cancer, but only a small percentage of children’s cancer programs have adopted it. The PAT assesses a wide range of family circumstances, including social supports, family health beliefs, family system challenges, and social determinants of health (the conditions in which families live, learn, and work that affect health outcomes). It automatically scores families into the three PPPHM risk levels listed above.

How the Study Was Designed

Eighteen children’s cancer programs agreed in writing to participate in 2018, before the study formally began. Programs were selected based on size — measured by number of new patients per year — and categorized as:

• Small: fewer than 50 new patients per year
• Medium: 50 to 149 new patients per year
• Large: more than 150 new patients per year

The researchers also gave priority to programs in states or regions with significant Spanish-speaking populations. Every site agreed to administer the PAT in English and Spanish as part of routine clinical care.

This was a cluster randomized controlled trial, meaning entire programs were randomized rather than individual families. Randomization was stratified (balanced) by site size. Programs were assigned to one of two implementation strategies (Strategy I or Strategy II) and to one of three year-long cohorts that started in 2021, 2022, and 2023. The first cohort began in 2021 with 6 sites — 2 small, 2 medium, and 2 large.

In total, 127 multidisciplinary providers enrolled across the three cohorts. Roles included:

• Site principal investigators (PIs), who were oncologists or psychologists
• Screeners, who were psychologists, social workers, child life specialists, and psychology trainees
• Champions (for Strategy II sites), who were oncologists and psychologists

Every site had at least 2 participants (a PI plus a screener); team sizes ranged from 3 to 17 people, with larger programs generally fielding larger teams.

Importantly, grant funding did not pay for the screeners themselves. Funding supported each site’s PI and a research coordinator who managed ethics board procedures and data transmission, but screening was absorbed into normal clinical work. This makes the study a realistic test of what programs can do with existing staff.

The Two Implementation Strategies

Strategy I combined two elements. The first was a professionally produced, 3-hour web-based training curriculum (WebTC) delivered virtually. The second was a written, site-specific PAT Implementation Plan completed by each program’s screening team before they started screening.

The WebTC had three segments:

1. Why screening matters: background on equitable psychosocial care, the development and measurement quality (psychometrics) of the PAT, and its use in clinical practice, including language-inclusive screening for Spanish-speaking families.
2. How to use the PAT: an item-by-item review of the questionnaire, scoring instructions, how to connect risk levels to recommended interventions, and related materials.
3. Building the Implementation Plan: guidance to help each site complete its own written plan during the final hour of the training.

The WebTC was not built in a vacuum. Its content and format were shaped by qualitative interviews with 19 community members, who shared what information providers need and what keeps them engaged in training and screening. The curriculum incorporated proven adult learning methods, including videos, demonstrations, and tailored case examples, along with video clips from presenters, existing PAT users, and families.

During the last hour of the WebTC, each site’s team worked together to complete its PAT Implementation Plan. The plan established clear expectations by asking: who screens, who will be screened, how the PAT will be scored, how screeners will give feedback to families, how screeners will share results with the care team, how results will guide clinical care, and what institutional considerations apply. Sites were allowed to screen a defined subpopulation of their cancer program (for example, inpatients or children with hematologic (blood) malignancies) — but within that group they were expected to screen every family. The plan also prompted sites to consider diversity in their cancer population and how to conduct screening in Spanish. Once submitted, the plan was reviewed and approved by the study PIs, and it functioned as a “living document” that teams could revise as challenges arose.

Strategy II included everything in Strategy I plus additional support, known collectively as TIER (Implementation Expanded Resources). TIER added:

• A Champion: a person chosen to support the screeners, troubleshoot barriers, promote what helps screening work, and build a culture that values screening. Champions advocated for psychosocial screening with clinicians and hospital leadership, tracked screening progress, and helped integrate the PAT into routine care. The role was intentionally broad so each site could tailor it. Across sites, champions included oncologists, nurse managers, and psychologists; 3 sites chose two champions.
• Consultation Calls: the 9 sites randomized to Strategy II participated in monthly, one-hour video calls during their cohort year, using a learning collaborative model in which sites discussed challenges and solutions with each other. Calls were facilitated by study staff and attended by each site’s PIs, screeners, and champion.

During the second cohort, one adaptation was made to the consultation calls to boost engagement: participants took turns sharing their screening successes from the past month, along with their barriers, and the group problem-solved together. Across the entire trial, this was the only documented modification to the planned implementation strategies.

Getting 18 Cancer Programs Ready to Screen

Preparation began six months before each cohort started. Because sites had originally committed to the study 2 to 4 years before their cohort began, the study team held two one-on-one “study launch calls” with each site PI. The first call reviewed the protocol in detail, asked sites to identify their research staff and screeners, and started the ethics board (IRB, or Institutional Review Board) process. The second call, held three months before the cohort year, revealed which strategy the site had been assigned to, discussed the Champion role for Strategy II sites, and confirmed that start-up steps were on track.

Anticipating staff turnover during the year, the study required site PIs to verify in writing that any new or unavailable staff watched the recorded WebTC and reviewed the PAT Implementation Plan as part of their onboarding. The Children’s Hospital of Philadelphia served as the central IRB of record (protocol number 19-017117), and the trial was registered at ClinicalTrials.gov under the identifier NCT04446728 on June 23, 2020.

The trial launched during the COVID-19 public health emergency in the United States and continued past its official end in May 2023. This required flexibility — for example, training participants sometimes wore masks or viewed the webinar from separate rooms. The research team systematically tracked all adaptations using a formal framework (the Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies), recording them in weekly meeting minutes and consultation call transcripts.

What the Researchers Measured

Each site sent monthly data to a central coordinating center at Nemours Children’s Health, including how many families were eligible, how many were screened, and what type of insurance each family had — used as a proxy (stand-in indicator) for socioeconomic status. Sites also reported which families identified as Hispanic, families’ identified race, and whether feedback was provided to families after screening.

A waiver of consent allowed the research team to collect caregivers’ PAT data, basic demographic and cancer-related information, and information about services families received, without requiring individual consent forms for each family.

Six months into the cohort year, all participants completed a questionnaire evaluating the WebTC:

• Five items rated how clear the WebTC was in conveying the importance of screening, background on the PAT, how to use it, the study rationale, and how to prepare the Implementation Plan.
• Five items rated how helpful the same content was. These 10 items used a 4-point scale (1 = strongly disagree, 4 = strongly agree).
• Eight additional items rated format, length, remote access platform, relevance, and interest, on a 4-point scale (1 = poor, 4 = excellent).

The research team used statistical analyses (ANOVAs, or analysis of variance tests) to compare the percentage of eligible families screened, Hispanic families screened, families screened by race, families screened by socioeconomic status, and feedback provided — across the two strategies.

Key Findings: Strategy I vs. Strategy II

The main result was clear: there were no differences between Strategy I and Strategy II. Adding consultation calls and a Champion did not increase the percentage of families screened compared to the web-based training plus Implementation Plan alone. This held true for every outcome measured:

1. Percentage of all eligible families screened
2. Percentage of eligible Hispanic families screened
3. Percentage of families screened by identified race
4. Percentage of families screened by socioeconomic status (using insurance type)
5. Percentage of families who received feedback after screening

In plain terms, the enhanced strategy was not better than the simpler one at getting families screened, including families from racial and ethnic minoritized groups, Spanish-speaking families, and families with lower socioeconomic status.

One interesting pattern emerged in exploratory analyses (additional analyses not part of the original main plan). When the researchers examined strategy, site size, and cohort together, they found lower percentages of families screened in the second cohort (which ran in 2022). The reasons are not fully explained by the data reported here.

Ratings of the training itself were positive. Participants rated the WebTC as clear and helpful in understanding the importance of screening and in learning how to screen as part of their normal workflow. In other words, the training did its job, even though more intensive follow-up support did not produce additional screening volume.

Another finding concerns how programs actually implemented screening. Most sites screened a subsample of their cancer program population — for example, only inpatients or only families of children with hematologic malignancies — rather than every family in their program. The screeners were most often social workers or psychologists. This tells us that, even in committed programs with formal implementation plans, true universal screening of the entire patient population remains difficult to achieve.

Four Key Contributions to the Field

The researchers summarized the study’s main contributions as follows:

• Implementation planning, combined with comprehensive training of screeners, supports successful psychosocial screening across diverse families and across small, medium, and large children’s cancer programs.
• Implementation planning using a structured PAT Implementation Plan — one that addresses barriers at the patient, provider, and institution levels — is indicated for screening all patients and families and for promoting equitable care.
• Despite clear commitment from sites (shown in their adoption, penetration, and health equity data), not all families identified for screening actually completed the PAT, and universal screening was not achieved.
• Further evaluation of multi-level factors — including barriers and facilitators — is needed to understand whether enhanced implementation strategies can be more effective in the future.

What This Means for Patients and Families

For families, the most important message is that screening tools like the PAT exist precisely to make care fairer and more personalized. When a program screens every family with the same questionnaire, it removes guesswork. A family does not have to look distressed or ask for help to receive support; screening proactively identifies who needs what.

The finding that both strategies worked equally well is actually encouraging. It suggests that a children’s cancer program does not need elaborate, expensive infrastructure to start screening families. A solid training program and a clear, written plan — covering who will screen, who will be screened, and how the team will respond to results — may be the essential ingredients, at least in the first year.

The study also demonstrates that screening can reach families who are often left out of mental health support. Hispanic families, Spanish-speaking families, families of color, and families with lower socioeconomic status were screened at similar rates regardless of strategy. That matters because these are exactly the families who face the greatest barriers to care and who have historically experienced worse cancer outcomes.

At the same time, the results are a sober reminder. Even with training, planning, consultation calls, and champions, most programs screened only a portion of their eligible families. Families whose children are treated at a program that screens only inpatients — or only families of children with blood cancers — may still miss out on assessment. Parents can advocate by asking their child’s care team: “Do you offer psychosocial screening for every family here?”

Study Limitations

This study was carefully designed, but it has important limitations that patients and readers should understand.

• Universal screening was not achieved. Because most sites screened a defined subgroup rather than their entire cancer population, the study measured penetration within subgroups, not true program-wide universal screening.
• Sites were self-selected. The 18 programs agreed in writing to participate years in advance. They were likely more motivated and committed to psychosocial screening than the average cancer program, which may limit how well the findings apply to less engaged sites.
• No difference between strategies. The study was designed to detect differences between Strategy I and Strategy II, and none were found. However, the enhanced supports (consultation calls and Champions) might matter more for sustaining screening over many years, which this one-year design could not measure.
• Cohort effects appeared. Screening rates were lower in the second cohort (2022), a reminder that external conditions — possibly ongoing COVID-19 disruptions, staffing changes, or other pressures — can affect implementation.
• Socioeconomic status was estimated, not measured. Insurance type is a useful proxy, but it does not capture the full complexity of a family’s financial situation.
• Race and ethnicity categories are broad. Grouping families into large categories can hide important differences within groups.

Recommendations for Cancer Programs

Based on what this trial showed, children’s cancer programs that want to start or improve psychosocial screening can take several practical steps:

1. Use a validated, structured screener like the PAT rather than relying on clinician judgment or unstructured interviews. A structured tool administered to everyone reduces bias and ensures all families are asked the same questions.
2. Offer screening in the languages families speak. This study used the PAT in English and Spanish, and equitable screening of Hispanic families was achieved. Language-inclusive screening should be a standard part of implementation planning.
3. Invest in comprehensive training before launching. A structured, recorded training curriculum that covers why screening matters, how to administer the tool, and how to score and act on results was rated as clear and helpful by participants.
4. Write an implementation plan. Before screening begins, decide who screens, who gets screened, how results will be shared with families and the medical team, and how results will guide care. Treat the plan as a living document that can change as challenges surface.
5. Plan for the full workflow. Training alone does not guarantee that every eligible family will be screened. Programs need to anticipate real-world barriers at the family level (language, stress, time), provider level (workload, turnover), and institution level (leadership support, competing demands).
6. Track equity data. Record not only how many families were screened, but also whether screening rates differ by race, ethnicity, language, and socioeconomic status. What gets measured gets managed.
7. Consider champions and peer consultation calls where sites face special challenges. This trial did not find that these extra supports increased screening in the first year, but they may still be valuable for troubleshooting, morale, and long-term sustainability. They should be chosen to fit each site’s specific needs rather than added uniformly.

Frequently Asked Questions

Why do children's cancer programs screen families for psychosocial needs?

Psychosocial care is a proven part of quality cancer treatment, and experts recommend that every family be asked in a consistent way about emotional, social, and practical challenges. Screening every family reduces bias, because care is based on answers to the same questions rather than on a clinician's personal judgment or assumptions.

What is the Psychosocial Assessment Tool (PAT)?

The PAT is a web-based questionnaire completed by a child's caregiver. It is validated in English and Spanish and assesses family circumstances such as social support, family health beliefs, and social determinants of health. It automatically sorts families into three risk levels: universal, targeted, or clinical.

If my family is screened, what happens with the results?

After screening, providers share the results with you and your care team, and results are used to guide clinical care. The risk level helps match your family to appropriate support. For example, most families need general support, while others may need more intensive services.

Will my child's cancer program screen every family?

Even with training and planning, most cancer programs in a study screened only part of their patient population, such as inpatients or families of children with blood cancers. Full universal screening was not achieved, even among committed programs. You can ask your child's team whether they offer screening to every family.

Are families from different racial, ethnic, or language backgrounds screened fairly?

In a national study of 18 U.S. children's cancer programs, screening reached families across racial, ethnic, language, and socioeconomic lines. Hispanic families, Spanish-speaking families, families of color, and families with lower socioeconomic status were screened at similar rates under both implementation strategies studied.

Does a cancer program need extra staff or expensive resources to start screening families?

A study found that a simpler strategy of web-based training plus a written implementation plan worked about as well as adding monthly consultation calls and a dedicated internal champion. This suggests that comprehensive training and a clear plan may be the essential ingredients for starting screening.

What can I do if I want my family to receive psychosocial screening?

You can ask your child's care team: "Do you offer psychosocial screening for every family here?" The study notes that even with training, not every eligible family completed screening, so families may still miss out on assessment unless they ask about it.

My child was recently diagnosed with cancer, but the hospital does not offer psychosocial screening to every family. Should I get a second opinion?

Psychosocial screening with a validated tool such as the Psychosocial Assessment Tool is a recommended standard for all children with cancer and their families. A large trial across 18 U.S. cancer programs found that such screening can be delivered fairly across racial, ethnic, and Spanish-speaking families when staff receive structured training and follow a written implementation plan. However, even committed programs often failed to screen every eligible family. If your program does not routinely assess families, a second opinion may help you understand whether your child’s treatment plan fully addresses psychological and social needs. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

This patient-friendly article is based on peer-reviewed research originally published in Implementation Science.

• Original article title: A comparative effectiveness trial for universal psychosocial screening with the Psychosocial Assessment Tool (PAT) across 18 childhood cancer programs in the United States: adoption, penetration, and health equity.